Biomatter raises $18M to make custom enzymes feel like catalog orders
Biomatter will use the Astanor-led round to open a 2,000-square-metre design-and-testing facility in Vilnius in 2027 and expand in the United States.
By RuntimeWire Staff · Published

Biomatter will use the Astanor-led round to open a 2,000-square-metre design-and-testing facility in Vilnius in 2027 and expand in the United States.